Clinical trial
Azilsartan/Amlodipine (Zacras) Combination Tablets LD & HD Specified Drug-use Survey "Long-term Use Survey"
NCT02181816 is registered in ClinicalTrials.gov with Takeda as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Azilsartan/Amlodipine (Zacras) Combination Tablets LD & HD Specified Drug-use Survey "Long-term Use Survey"
- Lead sponsor
- Takeda
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 26, 2014
- Completion date
- January 31, 2017
- Enrollment
- 1,090 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.